Science & Enterprise subscription

Follow us on Twitter

  • Results of a clinical trial show a multi-user computer game using virtual reality helps people recovering from a st… https://t.co/JjyGsh7nAj
    about 5 hours ago
  • New post on Science and Enterprise: Virtual Reality Helps Continue Stroke Rehab at Home https://t.co/yzE1i27U2I #Science #Business
    about 5 hours ago
  • Amazing guts by Hendrickson to do this interview. More than I got. Author on interview with Biden over shared exper… https://t.co/ryRKrotY9K
    about 9 hours ago
  • Researchers in the U.S. and Germany discovered a new source of antibiotics to fight drug-resistant bacteria from co… https://t.co/tPwIf9nhLB
    about 9 hours ago
  • New post on Science and Enterprise: New Antibiotic Discovered to Fight Drug-Resistant Bacteria https://t.co/wcJ3czM25x #Science #Business
    about 9 hours ago

Please share Science & Enterprise

T-Cells Engineered to Release Anti-Cancer Proteins

T-cells illustration

A biotechnology company is developing modified immune system cells programmed to sense and respond to cancer cells with targeted therapeutic proteins. . . . → Read More: T-Cells Engineered to Release Anti-Cancer Proteins

AstraZeneca Joins $1B Fund, Expands Footprint in China

Research lab in China

The pharmaceutical company AstraZeneca is starting a joint $1 billion health care investment fund in China and vastly increasing its labs and offices there. . . . → Read More: AstraZeneca Joins $1B Fund, Expands Footprint in China

MD Anderson, Biotech Partner on T-Cell Receptors

T lymphocyte

A cancer center and biotechnology company are creating treatments that target proteins on immune-system cells unique to each patient. . . . → Read More: MD Anderson, Biotech Partner on T-Cell Receptors

Real-World Evidence Assessed for Cancer Drug Trials

Assorted medical tools

Two medical technology companies are evaluating real-world evidence from patients to simulate randomized clinical trials for testing new cancer treatments. . . . → Read More: Real-World Evidence Assessed for Cancer Drug Trials

App Detects Early Eye Disease Symptoms from Photos

Eye measurements

In tests with thousands of children’s photographs, a smartphone app shows it can detect early symptoms of serious eye diseases, including cancer. . . . → Read More: App Detects Early Eye Disease Symptoms from Photos

Nanotech Crispr Delivery in Development

Editing a DNA strand

Researchers in biochemistry and structural biology are designing a technique using nanoscale particles to safely deliver edited genes as a cancer treatment. . . . → Read More: Nanotech Crispr Delivery in Development

Moderna Funding University Immunology Research

Immune - scrabble tiles

A biotechnology enterprise is financing a collaboration with Harvard Medical School that aims to discover new mechanisms for treating immune system disorders. . . . → Read More: Moderna Funding University Immunology Research

Biotech Developing Genome-Adjusting Disease Treatments

DNA analysis graphic

A new biotechnology enterprise is creating disease treatments that address regions in the genome precisely regulating expression of proteins. . . . → Read More: Biotech Developing Genome-Adjusting Disease Treatments

Start-Up Targets Extra DNA in Cancer, Raises $46.4M

Paul Mischel

A new biotechnology enterprise is developing treatments for aggressive solid tumor cancers that block the effects of DNA residing outside of chromosomes. . . . → Read More: Start-Up Targets Extra DNA in Cancer, Raises $46.4M

Gel, Crispr Help Defeat Cancer Drug Obstacles

Crispr-Cas9 illustration

A high-powered binding protein, formulated as a gel and targeted by Crispr gene editing is shown in lab mice to precisely deliver drugs and kill cancer cells. . . . → Read More: Gel, Crispr Help Defeat Cancer Drug Obstacles